propranolol has been researched along with Hyperglycemia in 114 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the involvement of the adrenergic system in nickel-induced hyperglycemia and hepatic glutathione depletion in rats, several adrenergic antagonists (phentolamine, prazosin, yohimbine, and propranolol) were administered in a single ip injection before acute nickel treatment (ip injection)." | 7.68 | Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats. ( Alvarez, C; Bladé, C; Cartañà, J, 1993) |
| "We previously reported that neostigmine injected into the third cerebral ventricle stimulated adrenal secretion of epinephrine, secretion of glucagon from the pancreas, and direct neural innervation of the liver, resulting in hepatic venous plasma hyperglycemia in anesthetized fed rats." | 7.68 | Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats. ( Gotoh, M; Iguchi, A; Matsunaga, H; Miura, H; Sakamoto, N; Satake, T; Tamagawa, T; Uemura, K; Yatomi, A, 1990) |
| "Intracranial injection of D-mannitol (MA) or D-glucose (GL) caused photoperiodic hyperglycemia in rats; MA injection elicited hyperglycemia only in the light period, while GL injection induced it only in the dark period." | 7.67 | Role of autonomic nervous system in the time-dependent hyperglycemia induced by intracranial injection of D-mannitol and D-glucose. ( Nagai, K; Nakagawa, H; Yamamoto, H, 1984) |
| "Diazinon, an organophosphorous compound, produced hyperglycemia and reduced the glycogen content of the brain 2 h after its administration to rats (40 mg/kg, i." | 7.67 | Influence of cholinergic and adrenergic blocking drugs on hyperglycemia and brain glycogenolysis in diazinon-treated animals. ( Ansari, RA; Husain, K, 1988) |
| "Two patients developed diabetic coma when taking a combination of a thiazide diuretic and propranolol." | 7.66 | Hyperglycemia and diabetic coma: possible relationship to diuretic-propranolol therapy. ( Bouma, DJ; Nardone, DA, 1979) |
| "Sepsis is accompanied by an enormous increase in catecholamine expression, leading to metabolism of lipids and glucose, changes in cardiovascular output, immunomodulatory effects, and changes in protein metabolism, all of which push the body into a catabolic state." | 6.44 | Metabolism modulators in sepsis: propranolol. ( Herndon, DN; Jeschke, MG; Norbury, WB, 2007) |
| "Pretreatment with propranolol suppressed olanzapine-induced elevations in the serum concentration of glucose, but did not affect the serum concentration of olanzapine or olanzapine-induced increase in the serum concentration of epinephrine." | 5.43 | Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine. ( Ishiwata, Y; Nagata, M; Nakajima, M; Negishi, K; Takahashi, H; Takahashi, Y; Yasuhara, M, 2016) |
| "Carvedilol treatment reversed thyroxin induced hypertriglyceridemia, whereas propranolol treatment had no effect." | 5.34 | Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. ( Bhatt, P; Goyal, R; Makwana, D; Santani, D, 2007) |
| " We have provided experimental evidence showing the suppressive effects of the nonselective β-adrenoreceptor antagonist propranolol on hyperglycemia, inflammation, and brain injury in a rat model experiencing cerebral ischemia." | 3.96 | Effects of β-Adrenergic Blockade on Metabolic and Inflammatory Responses in a Rat Model of Ischemic Stroke. ( Chang, CY; Chen, CJ; Chen, WY; Kuan, YH; Liao, SL; Lin, SY; Wang, YY; Wu, CC, 2020) |
| " Pre-treatment of rats with mifepristone (glucocorticoid receptor antagonist) prevented induction of liver tyrosine aminotransferase activity (TAT), but was ineffective in attenuating hyperglycemia induced by monocrotophos." | 3.78 | Insights into the mechanisms mediating hyperglycemic and stressogenic outcomes in rats treated with monocrotophos, an organophosphorus insecticide. ( Joshi, AK; Nagaraju, R; Rajini, PS, 2012) |
| " Addition of eugenosedin-A to the high-fat diet resulted in less weight gain and reduced hyperglycaemia, hyperinsulinaemia and hyperlipidaemia." | 3.75 | Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. ( Chen, IJ; Hsieh, SL; Kwan, AL; Lin, HL; Shen, KP; Wu, BN, 2009) |
| "The effect of adrenoceptor blockers on nicotine induced hyperglycemia were studied in fasted normal and thyroidectomised rats." | 3.70 | Effects of adrenoceptor blockers on the glycemic response to nicotine in thyroidectomised rats. ( Fasanmade, AA; Ogwumike, OO, 2000) |
| " By elevating Epi concentration and/or blocking beta-adrenoreceptors with propranolol (Prop), our goals were to investigate the mechanism for Epi-induced hyperglycemia to determine the possible role played by basal Epi concentration in maintaining resting R(a) glucose and to assess indirect effects of Epi in the intact animal." | 3.70 | Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes. ( Shanghavi, DS; Weber, JM, 2000) |
| "We previously reported that neostigmine injected into the third cerebral ventricle stimulated adrenal secretion of epinephrine, secretion of glucagon from the pancreas, and direct neural innervation of the liver, resulting in hepatic venous plasma hyperglycemia in anesthetized fed rats." | 3.68 | Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats. ( Gotoh, M; Iguchi, A; Matsunaga, H; Miura, H; Sakamoto, N; Satake, T; Tamagawa, T; Uemura, K; Yatomi, A, 1990) |
| "To study the involvement of the adrenergic system in nickel-induced hyperglycemia and hepatic glutathione depletion in rats, several adrenergic antagonists (phentolamine, prazosin, yohimbine, and propranolol) were administered in a single ip injection before acute nickel treatment (ip injection)." | 3.68 | Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats. ( Alvarez, C; Bladé, C; Cartañà, J, 1993) |
| "Intracranial injection of D-mannitol (MA) or D-glucose (GL) caused photoperiodic hyperglycemia in rats; MA injection elicited hyperglycemia only in the light period, while GL injection induced it only in the dark period." | 3.67 | Role of autonomic nervous system in the time-dependent hyperglycemia induced by intracranial injection of D-mannitol and D-glucose. ( Nagai, K; Nakagawa, H; Yamamoto, H, 1984) |
| "Previously we found that in rats, electrical stimulation of the suprachiasmatic nucleus (SCN) of the hypothalamus elicited hyperglycemia associated with hyperglucagonemia without immediate hyperinsulinemia." | 3.67 | Involvement of adrenergic mechanism in hyperglycemia due to SCN stimulation. ( Fujii, T; Inoue, S; Nagai, K; Nakagawa, H, 1989) |
| "Diazinon, an organophosphorous compound, produced hyperglycemia and reduced the glycogen content of the brain 2 h after its administration to rats (40 mg/kg, i." | 3.67 | Influence of cholinergic and adrenergic blocking drugs on hyperglycemia and brain glycogenolysis in diazinon-treated animals. ( Ansari, RA; Husain, K, 1988) |
| "Electrical stimulation of the lateral part of the dorsal parabrachial nucleus (PBD) induces hyperglycemia by enhancing glucagon secretion and suppressing insulin secretion in rats." | 3.67 | Hyperglycemia induced by electrical stimulation of lateral part of dorsal parabrachial nucleus. ( Fujiwara, T; Nagai, K; Nakagawa, H; Takagi, S, 1988) |
| "To determine the mechanism of time-dependent hyperglycemia due to intracranial injection of 2-deoxy-D-glucose (2DG), we examined the effects of various blockers of the autonomic nervous system on the hyperglycemia and hyperglucagonemia induced by intracranial injection of 2DG in male Wistar rats in light and dark periods." | 3.67 | Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose. ( Nagai, K; Nakagawa, H; Yamamoto, H, 1988) |
| " The beta-endorphin-induced hyperglycemia was reduced by naloxone (+0." | 3.67 | Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits. ( Knudtzon, J, 1986) |
| " Administration of the beta-adrenergic agonist isoproterenol during the period of insulin resistance (days 26-40 after primary immunization), largely restored fat cell responsiveness to insulin, and eliminated the appearance of fasting hyperglycemia." | 3.67 | Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists. ( Cohen, IR; Elias, D; Rapoport, M; Shechter, Y, 1988) |
| "5-2 mg/kg), chlorpheniramine (1-4 mg/kg) and promethazine (1-4 mg/kg), inhibited dose-dependently the HA-induced hyperglycemia, whereas an H2-receptor antagonist, cimetidine (80 nmol i." | 3.67 | Mechanism of the central hyperglycemic action of histamine in mice. ( Itoh, Y; Nishibori, M; Oishi, R; Saeki, K, 1987) |
| " On the other hand, this hyperglycemia was partially blocked either by the treatment of intact rats with propranolol, beta-adrenergic blocker, or by adrenalectomy." | 3.66 | Hyperglycemic effect of hydralazine in rats. ( Hara, S; Kitagawa, H; Satoh, T; Takashima, M, 1980) |
| "Two patients developed diabetic coma when taking a combination of a thiazide diuretic and propranolol." | 3.66 | Hyperglycemia and diabetic coma: possible relationship to diuretic-propranolol therapy. ( Bouma, DJ; Nardone, DA, 1979) |
| " These five groups were then compared on the basis of their insulin response during the oral glucose tolerance test and on the ability of exogenously infused insulin to limit hyperglycemia during a continuous infusion of glucose and insulin, while endogenous insulin was inhibited by the infusion of epinephrine and propranolol." | 3.65 | Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? ( Bernstein, R; Davis, B; Olefsky, JM; Reaven, GM, 1976) |
| "Isoproterenol and propranolol, in a single dose, caused hyperglycemia after 15 and 30 min, either in the conscious rat or in the anesthetized dog." | 3.65 | Metabolic responses to catecholamines. ( Aramendía, P; Márquez, MT; Puntoni de Mikulic, LE, 1976) |
| "The insulin resistance is due to beta-adrenergic stimulation and can be prevented by propranolol." | 2.66 | Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation. ( Attvall, S; Fowelin, J; Lager, I; Smith, U; von Schenck, H, 1987) |
| "Sepsis is accompanied by an enormous increase in catecholamine expression, leading to metabolism of lipids and glucose, changes in cardiovascular output, immunomodulatory effects, and changes in protein metabolism, all of which push the body into a catabolic state." | 2.44 | Metabolism modulators in sepsis: propranolol. ( Herndon, DN; Jeschke, MG; Norbury, WB, 2007) |
| "Pretreatment with propranolol suppressed olanzapine-induced elevations in the serum concentration of glucose, but did not affect the serum concentration of olanzapine or olanzapine-induced increase in the serum concentration of epinephrine." | 1.43 | Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine. ( Ishiwata, Y; Nagata, M; Nakajima, M; Negishi, K; Takahashi, H; Takahashi, Y; Yasuhara, M, 2016) |
| "Therapeutic potential of agomelatine on neuropathic pain was suppressed with α-methyl-para-tyrosine methyl ester (an inhibitor of catecholamine synthesis), phentolamine (a nonselective α-adrenoceptor antagonist), and propranolol (a nonselective β-adrenoceptor antagonist) administrations." | 1.43 | Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms. ( Aydın, TH; Can, ÖD; Demir Özkay, Ü; Turan, N, 2016) |
| "Carvedilol treatment reversed thyroxin induced hypertriglyceridemia, whereas propranolol treatment had no effect." | 1.34 | Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study. ( Bhatt, P; Goyal, R; Makwana, D; Santani, D, 2007) |
| " 5-CT above the dosage of 0." | 1.30 | Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats. ( Noma, T; Sugimoto, Y; Yamada, J; Yoshikawa, T, 1998) |
| " Dose-response curves with epinephrine from lean mice were best fit to a two-component model comprised of 23% high affinity (K(act) = 1." | 1.29 | Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. ( Collins, S; Daniel, KW; Gettys, TW; Ramkumar, V; Rohlfs, EM; Taylor, IL, 1994) |
| " Toxic levels of theophylline were associated with hypokalemia, hypophosphatemia, hyperglycemia, metabolic acidosis, and hypotension in both the patient and the experimental series." | 1.27 | Theophylline toxicity and the beta-adrenergic system. ( Curtis, GP; Kearney, TE; Manoguerra, AS; Ziegler, MG, 1985) |
| "Xylazine was administered intravenously (0." | 1.26 | Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep. ( Brockman, RP; Muggaberg, J, 1982) |
| "Insulin resistance was estimated by measuring the steady-state plasma glucose response to a continuous infusion of insulin, glucose, epinephrine, and propranolol." | 1.26 | Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus. ( Javorski, C; Kimmerling, G; Olefsky, JM; Reaven, GM, 1976) |
| "Propranolol pretreatment (5 mg/kg) does not affect the DPH-induced changes in blood glucose, plasma insulin and plasma glucagon." | 1.26 | Studies on the hyperglycemic effect of diphenylhydantoin in normal golden hamsters. ( Lefebvre, PJ; Luyckx, AS; Tamburrano, S, 1976) |
| "Glycogen was depleted only by amphetamine-like compounds or by bemegride-induced convulsions." | 1.25 | Physiological and drug-induced changes in the glycogen content of mouse brain. ( Hutchins, DA; Rogers, KJ, 1970) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 87 (76.32) | 18.7374 |
| 1990's | 9 (7.89) | 18.2507 |
| 2000's | 10 (8.77) | 29.6817 |
| 2010's | 7 (6.14) | 24.3611 |
| 2020's | 1 (0.88) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, SY | 1 |
| Wang, YY | 1 |
| Chang, CY | 1 |
| Wu, CC | 1 |
| Chen, WY | 1 |
| Kuan, YH | 1 |
| Liao, SL | 1 |
| Chen, CJ | 1 |
| Kayano, R | 1 |
| Morofuji, Y | 1 |
| Nakagawa, S | 1 |
| Fukuda, S | 1 |
| Watanabe, D | 1 |
| Ozawa, H | 1 |
| Niwa, M | 2 |
| Matsuo, T | 1 |
| Shepherd, SJ | 1 |
| Newman, R | 1 |
| Brett, SJ | 1 |
| Griffith, DM | 1 |
| Nagata, M | 1 |
| Nakajima, M | 1 |
| Ishiwata, Y | 1 |
| Takahashi, Y | 1 |
| Takahashi, H | 1 |
| Negishi, K | 1 |
| Yasuhara, M | 1 |
| Aydın, TH | 1 |
| Can, ÖD | 1 |
| Demir Özkay, Ü | 1 |
| Turan, N | 1 |
| Shen, KP | 1 |
| Lin, HL | 1 |
| Hsieh, SL | 1 |
| Kwan, AL | 1 |
| Chen, IJ | 1 |
| Wu, BN | 1 |
| Salahdeen, HM | 1 |
| Alada, AR | 3 |
| Wintergerst, KA | 1 |
| Rogers, ES | 1 |
| Foster, MB | 1 |
| Joshi, AK | 1 |
| Nagaraju, R | 1 |
| Rajini, PS | 1 |
| Ruohonen, ST | 1 |
| Ruohonen, S | 1 |
| Gilsbach, R | 1 |
| Savontaus, E | 1 |
| Scheinin, M | 1 |
| Hein, L | 1 |
| Ekhelar, AI | 1 |
| Oyebola, OD | 1 |
| Park, C | 1 |
| Yang, I | 1 |
| Woo, J | 1 |
| Kim, S | 1 |
| Kim, J | 1 |
| Kim, Y | 1 |
| Park, S | 1 |
| Bhatt, P | 1 |
| Makwana, D | 1 |
| Santani, D | 1 |
| Goyal, R | 1 |
| Norbury, WB | 1 |
| Jeschke, MG | 1 |
| Herndon, DN | 1 |
| Salvador, RA | 1 |
| April, SA | 1 |
| Lemberger, L | 1 |
| Opie, LH | 1 |
| Acheson, K | 1 |
| Jéquier, E | 2 |
| Wahren, J | 1 |
| Cryer, PE | 4 |
| Tse, TF | 1 |
| Clutter, WE | 1 |
| Shah, SD | 1 |
| Yamamoto, H | 2 |
| Nagai, K | 5 |
| Nakagawa, H | 4 |
| Rizza, RA | 2 |
| Haymond, MW | 2 |
| Gerich, JE | 4 |
| Satoh, T | 1 |
| Hara, S | 1 |
| Takashima, M | 1 |
| Kitagawa, H | 1 |
| Johansson, SR | 1 |
| Andersson, RG | 1 |
| Ribes, G | 1 |
| Blayac, JP | 1 |
| Loubatieres-Mariani, MM | 1 |
| Goldstein, RA | 1 |
| Mullani, NA | 1 |
| Marani, SK | 1 |
| Fisher, DJ | 1 |
| Gould, KL | 1 |
| O'Brien, HA | 1 |
| Muggaberg, J | 1 |
| Brockman, RP | 1 |
| Miles, JM | 1 |
| Verdonk, CA | 1 |
| Chevaux, F | 1 |
| Shapiro, AP | 1 |
| Traub, YM | 1 |
| Nonogaki, K | 1 |
| Iguchi, A | 3 |
| Sakamoto, N | 3 |
| Oyebola, DD | 1 |
| Collins, S | 1 |
| Daniel, KW | 1 |
| Rohlfs, EM | 1 |
| Ramkumar, V | 1 |
| Taylor, IL | 1 |
| Gettys, TW | 1 |
| Alvarez, C | 1 |
| Bladé, C | 1 |
| Cartañà, J | 1 |
| Yamada, J | 2 |
| Sugimoto, Y | 2 |
| Noma, T | 1 |
| Yoshikawa, T | 2 |
| Weber, JM | 1 |
| Shanghavi, DS | 1 |
| Rashid, S | 1 |
| Shi, ZQ | 1 |
| Mathoo, JM | 1 |
| Vandelangeryt, ML | 1 |
| Bilinski, D | 1 |
| Lewis, GF | 1 |
| Vranic, M | 1 |
| Ogwumike, OO | 1 |
| Fasanmade, AA | 1 |
| Gürün, MS | 1 |
| Ilçöl, YO | 1 |
| Taga, Y | 1 |
| Ulus, IH | 1 |
| Bouvenot, G | 1 |
| Escande, M | 1 |
| Jouve, R | 1 |
| Delboy, C | 1 |
| Bercher, H | 1 |
| Grisk, A | 1 |
| Dehaye, JP | 1 |
| Winand, J | 1 |
| Christophe, J | 1 |
| Lager, I | 2 |
| Blohmé, G | 1 |
| Smith, U | 2 |
| McCloy, RF | 1 |
| Dawson, VA | 1 |
| Baron, JH | 1 |
| Inglis, RJ | 1 |
| Clissiounis, N | 1 |
| Reaven, GM | 6 |
| Nardone, DA | 1 |
| Bouma, DJ | 1 |
| Koch-Weser, J | 1 |
| Bernstein, R | 1 |
| Davis, B | 1 |
| Olefsky, JM | 3 |
| Kimmerling, G | 2 |
| Javorski, C | 1 |
| Frohman, LA | 2 |
| Puntoni de Mikulic, LE | 1 |
| Márquez, MT | 1 |
| Aramendía, P | 1 |
| Lorenzi, M | 1 |
| Tsalikian, E | 1 |
| Karam, JH | 1 |
| Ginsberg, H | 1 |
| Skikama, H | 1 |
| Ui, M | 1 |
| Holland, OB | 1 |
| Kaplan, NM | 1 |
| Tamburrano, S | 1 |
| Luyckx, AS | 1 |
| Lefebvre, PJ | 1 |
| Foss, A | 1 |
| Ahrén, B | 2 |
| Albertini, R | 1 |
| Vargas, L | 1 |
| Yatomi, A | 1 |
| Gotoh, M | 2 |
| Matsunaga, H | 2 |
| Uemura, K | 1 |
| Miura, H | 1 |
| Satake, T | 1 |
| Tamagawa, T | 1 |
| Fujii, T | 1 |
| Inoue, S | 1 |
| Yü, CC | 1 |
| Hua, HA | 1 |
| Tong, C | 1 |
| Attvall, S | 1 |
| Fowelin, J | 1 |
| von Schenck, H | 1 |
| Moratinos, J | 1 |
| Carpene, C | 1 |
| de Pablos, I | 1 |
| Reverte, M | 1 |
| Husain, K | 1 |
| Ansari, RA | 1 |
| Dornhorst, A | 1 |
| Powell, SH | 1 |
| Pensky, J | 1 |
| Marubashi, S | 1 |
| Tominaga, M | 1 |
| Katagiri, T | 1 |
| Yamatani, K | 1 |
| Yawata, Y | 1 |
| Hara, M | 1 |
| Sasaki, H | 1 |
| Campbell, PJ | 1 |
| Bolli, GB | 1 |
| Ohuchi, M | 1 |
| Nomura, T | 1 |
| Fujiwara, T | 1 |
| Takagi, S | 1 |
| Brunicardi, FC | 1 |
| Druck, P | 1 |
| Seymour, NE | 1 |
| Sun, YS | 1 |
| Gingerich, RL | 1 |
| Elahi, D | 1 |
| Andersen, DK | 1 |
| Knudtzon, J | 1 |
| Kearney, TE | 1 |
| Manoguerra, AS | 1 |
| Curtis, GP | 1 |
| Ziegler, MG | 1 |
| Beylot, M | 1 |
| Sautot, G | 1 |
| Dechaud, H | 1 |
| Cohen, R | 1 |
| Riou, JP | 1 |
| Serusclat, P | 1 |
| Mornex, R | 1 |
| Lindskog, S | 1 |
| Tatemoto, K | 1 |
| Efendić, S | 1 |
| Elias, D | 1 |
| Rapoport, M | 1 |
| Cohen, IR | 1 |
| Shechter, Y | 1 |
| Nishibori, M | 1 |
| Itoh, Y | 1 |
| Oishi, R | 1 |
| Saeki, K | 1 |
| Keller, R | 1 |
| Beeger, I | 1 |
| Berlan, M | 1 |
| Baïsset, MA | 1 |
| Agid, MR | 1 |
| Antonis, A | 1 |
| Clark, ML | 1 |
| Hodge, RL | 1 |
| Molony, M | 1 |
| Pilkington, TR | 1 |
| Pinter, EJ | 1 |
| Pattee, CJ | 1 |
| Peterfy, G | 1 |
| Cleghorn, JM | 1 |
| Reveno, WS | 1 |
| Rosenbaum, H | 1 |
| Opitz, K | 1 |
| Chu, H | 1 |
| Cronholm, LS | 1 |
| Fishel, CW | 1 |
| Nakamura, Y | 1 |
| Takemura, Y | 1 |
| Yamada, T | 1 |
| Baïsset, A | 1 |
| Dang-Tran, L | 1 |
| Montastruc, P | 1 |
| Jori, A | 1 |
| Carrara, MC | 1 |
| Sato, T | 1 |
| Wagner, J | 1 |
| Mennear, JH | 1 |
| Spratto, GR | 1 |
| Miya, TS | 1 |
| Duyckaerts, C | 1 |
| Atkins, T | 1 |
| Matty, AJ | 1 |
| Kokka, N | 1 |
| Eisenberg, RM | 1 |
| Garcia, J | 1 |
| George, R | 1 |
| Nash, CB | 1 |
| Smith, RD | 1 |
| Perrier, H | 1 |
| Perrier, C | 1 |
| Gras, J | 1 |
| Gothelf, B | 1 |
| Ellis, S | 1 |
| Khosla, P | 1 |
| Garg, KN | 1 |
| Cerchio, GM | 1 |
| Persico, PA | 1 |
| Müller, EE | 1 |
| Cocchi, D | 1 |
| Olefsky, J | 1 |
| Farquhar, JW | 2 |
| Reaven, G | 1 |
| Swenson, RS | 1 |
| Peterson, DT | 1 |
| Eshleman, M | 1 |
| Timsit, J | 1 |
| Giroud, JP | 1 |
| Dechezleprĕtre, S | 1 |
| Lechat, P | 1 |
| Kersh, ES | 1 |
| Schwartz, LK | 1 |
| Mendizabal, EM | 1 |
| Steinbock, MW | 1 |
| Sapira, JD | 1 |
| Avruskin, TW | 1 |
| Tang, SC | 1 |
| Juan, CS | 1 |
| Oneda, A | 1 |
| Adnitt, PI | 1 |
| Hutchins, DA | 1 |
| Rogers, KJ | 1 |
| Massara, F | 1 |
| Strumia, E | 1 |
| Walfish, PG | 1 |
| Natale, R | 1 |
| Chang, C | 1 |
| Shen, SW | 1 |
| Vinik, A | 1 |
| Pimstone, B | 1 |
| Buchanan-Lee, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by the Funny Channel Current (If) Inhibitor Ivabradine"[NCT01186783] | Phase 2 | 70 participants (Anticipated) | Interventional | 2010-05-31 | Recruiting | ||
| Relationship Between Insulin Resistance and Statin Induced Type 2 Diabetes, and Integrative Personal Omics Profiling[NCT02437084] | Phase 4 | 115 participants (Actual) | Interventional | 2015-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Baseline and end-of-treatment fasting plasma glucose (mg/dL) values represent average of up to 3 measurements for each value (obtained at baseline weeks -2, -1, and 0 and at the end of study at weeks 8, 9, and 10). (NCT02437084)
Timeframe: 10 weeks
| Intervention | mg/dL (Median) | |
|---|---|---|
| Baseline | End of Study | |
| Individuals Without Diabetes Eligible to Receive Statin Therapy | 99 | 100 |
Baseline and end-of-treatment fasting plasma insulin (mU/L) values represent average of up to 3 measurements for each value (obtained at baseline weeks -2, -1, and 0 and at the end of study at weeks 8, 9, and 10). (NCT02437084)
Timeframe: 10 weeks
| Intervention | mU/L (Median) | |
|---|---|---|
| Baseline | End of Study | |
| Individuals Without Diabetes Eligible to Receive Statin Therapy | 10.1 | 10.6 |
Insulin secretion measured by ISR-AUC (pmol/min x 4 h) during the graded glucose infusion test. (NCT02437084)
Timeframe: baseline, week 9 or 10
| Intervention | pmol/min x 4 h (Median) | |
|---|---|---|
| Baseline | End of Study | |
| Individuals Without Diabetes Eligible to Receive Statin Therapy | 1824 | 1942 |
Glucose area under the curve (AUC) (mg/dL x 2 h) measured during a 75-gram oral glucose tolerance test (OGTT). (NCT02437084)
Timeframe: baseline, week 8
| Intervention | mg/dL x 2 h (Median) | |
|---|---|---|
| Baseline | End of Study | |
| Individuals Without Diabetes Eligible to Receive Statin Therapy | 295 | 299 |
Insulin area under the curve (AUC) (mU/L x 2h) measured during a 75-gram oral glucose tolerance test (OGTT). (NCT02437084)
Timeframe: baseline, week 8
| Intervention | mU/L x 2 h (Median) | |
|---|---|---|
| Baseline | End of Study | |
| Individuals Without Diabetes Eligible to Receive Statin Therapy | 127 | 133 |
Insulin sensitivity measured by SSPG concentration (mg/dL) during the insulin suppression test. (NCT02437084)
Timeframe: baseline, week 9 or 10
| Intervention | mg/dL (Median) | |
|---|---|---|
| Baseline | End of Study | |
| Individuals Without Diabetes Eligible to Receive Statin Therapy | 130 | 139 |
7 reviews available for propranolol and Hyperglycemia
| Article | Year |
|---|---|
Pharmacological Therapy for the Prevention and Treatment of Weakness After Critical Illness: A Systematic Review.
Topics: Adrenergic beta-Antagonists; Anabolic Agents; Critical Illness; Glutamine; Growth Hormone; Humans; H | 2016 |
Metabolism modulators in sepsis: propranolol.
Topics: Adrenergic beta-Antagonists; Cytokines; Energy Metabolism; Humans; Hyperglycemia; Lipolysis; Propran | 2007 |
Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Glucose; Heart Rate; Heparin; Humans; Hyaluron | 1980 |
Diazoxide.
Topics: Blood Pressure; Cardiac Output; Diazoxide; Diuretics; Drug Synergism; Emergencies; Female; Half-Life | 1976 |
Is the basic lesion in diabetes insulin deficiency or insulin resistance?
Topics: Blood Glucose; Diabetes Complications; Diabetes Mellitus; Epinephrine; Glucose; Humans; Hyperglycemi | 1976 |
[Contribution to the pharmacology of the beta-adrenolytics].
Topics: Adrenergic beta-Antagonists; Anesthesia, Local; Animals; Arousal; Arrhythmias, Cardiac; Asthma; Card | 1970 |
[Growth hormone and carbohydrate metabolism].
Topics: Acromegaly; Animals; Carbohydrate Metabolism; Diabetes Mellitus; Dogs; Glucagon; Growth Hormone; Hum | 1971 |
4 trials available for propranolol and Hyperglycemia
| Article | Year |
|---|---|
Acute hyperglycemia and activation of the beta-adrenergic system exhibit synergistic inhibitory actions on growth hormone (GH) releasing hormone-induced GH release.
Topics: Acute Disease; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Drug Synergism; Growth | 2003 |
Effect of cardioselective and non-selective beta-blockade on the hypoglycaemic response in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; Blood Pressure; Bradycardia; Clinical Trials as Topic; Diabetes Mellitus; Dias | 1979 |
Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Female; Heart Rate; Humans; Hyperglycemia; Hypoglyc | 1987 |
Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetics without alteration of insulin secretion.
Topics: Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Synergism; Drug Thera | 1985 |
103 other studies available for propranolol and Hyperglycemia
| Article | Year |
|---|---|
Effects of β-Adrenergic Blockade on Metabolic and Inflammatory Responses in a Rat Model of Ischemic Stroke.
Topics: Adrenergic beta-Antagonists; Animals; Brain Injuries; Cell Line; Cytokines; Disease Models, Animal; | 2020 |
In vitro analysis of drugs that improve hyperglycemia-induced blood-brain barrier dysfunction.
Topics: Animals; Benzimidazoles; Biphenyl Compounds; Blood-Brain Barrier; Cilostazol; Disease Models, Animal | 2018 |
Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Corticosterone; Epinephrine; Glucagon | 2016 |
Effect of subacute agomelatine treatment on painful diabetic neuropathy: involvement of catecholaminergic mechanisms.
Topics: Acetamides; Animals; Blood Glucose; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Neurop | 2016 |
Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet.
Topics: Adipose Tissue; Animals; Atorvastatin; Blood Glucose; Body Weight; Brain; Dietary Fats; Female; Glut | 2009 |
Role of adrenergic receptors in the caffeine-induced increase in glucose uptake by the canine hindlimb.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Biological Transport; Blood Gluc | 2009 |
Hyperthyroidism presenting with hyperglycemia in an adolescent female.
Topics: Adolescent; Adrenergic beta-Antagonists; Antithyroid Agents; Blood Glucose; Female; Graves Disease; | 2011 |
Insights into the mechanisms mediating hyperglycemic and stressogenic outcomes in rats treated with monocrotophos, an organophosphorus insecticide.
Topics: Animals; Atropine; Blood Glucose; Corticosterone; Enzyme Induction; Epinephrine; Hyperglycemia; Inse | 2012 |
Involvement of α2-adrenoceptor subtypes A and C in glucose homeostasis and adrenaline-induced hyperglycaemia.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals | 2012 |
Effect of adrenaline on the glucose uptake by the canine hindlimb.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood | 2002 |
Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
Topics: Adrenergic beta-Antagonists; Animals; Appetite; Blood Glucose; Blood Pressure; Body Mass Index; Body | 2007 |
Inhibition by butoxamine, propranolol and MJ1999 of the glycogenolytic action of the catecholamines in the rat.
Topics: Animals; Butylamines; Catecholamines; Epinephrine; Fasting; Glycogen; Hyperglycemia; Isoproterenol; | 1967 |
Influence of beta-adrenergic blockade on glucose-induced thermogenesis in man.
Topics: Adrenergic beta-Antagonists; Adult; Basal Metabolism; Body Temperature Regulation; Energy Metabolism | 1983 |
Roles of glucagon and epinephrine in hypoglycemic and nonhypoglycemic glucose counterregulation in humans.
Topics: Adrenalectomy; Blood Glucose; Epinephrine; Glucagon; Growth Hormone; Humans; Hyperglycemia; Hypoglyc | 1984 |
Role of autonomic nervous system in the time-dependent hyperglycemia induced by intracranial injection of D-mannitol and D-glucose.
Topics: Animals; Atropine; Autonomic Nervous System; Circadian Rhythm; Darkness; Glucose; Hexamethonium; Hex | 1984 |
Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Topics: Adult; Blood Glucose; Epinephrine; Glucagon; Humans; Hyperglycemia; Insulin; Male; Phentolamine; Pro | 1980 |
Hyperglycemic effect of hydralazine in rats.
Topics: Adrenal Glands; Animals; Cyclic AMP; Female; Glycogen; Hydralazine; Hyperglycemia; Male; Phentolamin | 1980 |
Decrease of some metabolic and physiologic effects of diazoxide by propranolol in rat.
Topics: Animals; Blood Pressure; Cyclic AMP; Diazoxide; Drug Interactions; Female; Hyperglycemia; Liver; Pro | 1981 |
Differences between the effects of adrenaline and noradrenaline on insulin secretion in the dog.
Topics: Animals; Blood Glucose; Blood Pressure; Dogs; Duodenum; Epinephrine; Hyperglycemia; Insulin; Insulin | 1983 |
Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions.
Topics: Animals; Coronary Circulation; Digoxin; Dogs; Heart; Hydrogen-Ion Concentration; Hyperglycemia; Meth | 1983 |
Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep.
Topics: Animals; Blood Glucose; Glucagon; Hyperglycemia; Insulin; Phentolamine; Propranolol; Sheep; Sheep Di | 1982 |
Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man.
Topics: Adult; Blood Glucose; Epinephrine; Female; Glucagon; Humans; Hyperglycemia; Insulin; Male; Phentolam | 1980 |
Influence of plasma glucose and insulin concentrations on carbohydrate oxidation in man.
Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Epinephrine; Female; Glucose; Humans; Hyperglycemia; | 1982 |
Complications of antihypertensive therapy.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Female; Guanethidine; Humans; Hydr | 1981 |
Effects of adrenoceptor antagonists on the hyperthermia and hyperglycemia induced by prostaglandin F2 alpha in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Glucose; Body Temperature; Dinoprost; Fever; Hyperglyce | 1994 |
Effects of adrenergic receptor blockers on adrenaline and nicotine-induced hyperglycaemia in the rat.
Topics: Animals; Blood Glucose; Disease Models, Animal; Dogs; Epinephrine; Hyperglycemia; Male; Nicotine; Pr | 1993 |
Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
Topics: Adenylyl Cyclases; Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adrenergic beta- | 1994 |
Alpha 2-adrenergic blockade prevents hyperglycemia and hepatic glutathione depletion in nickel-injected rats.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Female; Glucagon; Glutathione; Hypergly | 1993 |
Effects of the non-selective 5-HT receptor agonist, 5-carboxamidotryptamine, on plasma glucose levels in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Blood Glucose; Glucagon; Hyperglycemia; Insulin; Ma | 1998 |
p-Chloroamphetamine, a serotonin-releasing drug, elicited in rats a hyperglycemia mediated by the 5-HT1A and 5-HT2B/2C receptors.
Topics: 4-Aminobenzoic Acid; Adrenal Medulla; Adrenalectomy; Aminopyridines; Animals; Blood Glucose; Dose-Re | 1998 |
Regulation of glucose production in rainbow trout: role of epinephrine in vivo and in isolated hepatocytes.
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Cell Fractionation; Cells, Cultured; Dose | 2000 |
Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Carbachol; Diabetes Mellitus, Experimental; Dog | 2000 |
Effects of adrenoceptor blockers on the glycemic response to nicotine in thyroidectomised rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Disease Models, A | 2000 |
Hyperglycemia induced by intracerebroventricular choline: involvement of the sympatho-adrenal system.
Topics: Adrenal Glands; Adrenalectomy; Animals; Atropine; Blood Glucose; Choline; Cholinergic Agents; Dose-R | 2002 |
[Beta blockaders and general pathology].
Topics: Acebutolol; Adrenergic beta-Antagonists; Asthma; Female; Humans; Hypercalcemia; Hyperglycemia; Hypog | 1977 |
[The effect of fluoridated phenylethanolamines on hyperglycemia induced by catecholamines in the rat].
Topics: Animals; Catecholamines; Drug Antagonism; Epinephrine; Ethanolamines; Female; Hyperglycemia; Isoprot | 1975 |
Effect of lipolytic agents on calcium uptake in the epididymal adipose tissue of obese-hyperglycemic mice and their lean controls [proceedings].
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Animals; Bucladesine; Calcium; Epinephrine; Glucagon; H | 1977 |
The effect of salbutamol and propranolol on pentagastrin, histamine and meal-stimulated acid and pepsin secretion in the dog.
Topics: Albuterol; Animals; Blood Glucose; Dogs; Dose-Response Relationship, Drug; Gastric Fistula; Gastric | 1979 |
Maturity-onset diabetes.
Topics: Diabetes Mellitus; Humans; Hyperglycemia; Male; Propranolol | 1979 |
Effect of adrenergic drugs on morphine-induced hyperglycemia.
Topics: Animals; Dihydroergotoxine; Female; Hyperglycemia; Iproniazid; Male; Monoamine Oxidase Inhibitors; M | 1979 |
Insulin resistance and insulin secretion in patients with chemical diabetes: implications concerning the pathogenesis of idiopathic diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus; Epinephrine; Fasting; Glucose Tolerance Test; Humans; Hyperglycemi | 1979 |
Hyperglycemia and diabetic coma: possible relationship to diuretic-propranolol therapy.
Topics: Diabetic Coma; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hyperglycemia; Hyp | 1979 |
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?
Topics: Adult; Diabetes Mellitus; Diabetic Ketoacidosis; Epinephrine; Female; Glucose Tolerance Test; Humans | 1976 |
Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus.
Topics: Adult; Diabetes Mellitus; Epinephrine; Fasting; Glucose; Glucose Tolerance Test; Homeostasis; Humans | 1976 |
Hyperglycemia and hyperglucagonemia following neurotensin administration.
Topics: Adrenal Medulla; Animals; Dose-Response Relationship, Drug; Glucagon; Hyperglycemia; Hypothalamus; I | 1976 |
Metabolic responses to catecholamines.
Topics: Animals; Catecholamines; Dogs; Drug Interactions; Epinephrine; Hyperglycemia; Hyperkalemia; Hypokale | 1976 |
Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Drug Synergism; Epinephrine; Fatty Acids, Nonesteri | 1976 |
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia.
Topics: Adult; Aged; Chronic Disease; Diabetes Complications; Diabetes Mellitus; Epinephrine; Fasting; Femal | 1975 |
Adrenergic receptor and epinephrine-induced hyperglycemia and glucose tolerance.
Topics: Animals; Bicarbonates; Blood Glucose; Carbon Radioisotopes; Epinephrine; Glucose; Hyperglycemia; Ind | 1975 |
Propranolol in the treatment of hypertension.
Topics: Arrhythmias, Cardiac; Brain; Bronchial Spasm; Depression, Chemical; Diuretics; Drug Synergism; Heart | 1976 |
Studies on the hyperglycemic effect of diphenylhydantoin in normal golden hamsters.
Topics: Animals; Blood Glucose; Cricetinae; Glucagon; Hyperglycemia; Insulin; Male; Phentolamine; Phenytoin; | 1976 |
Insulin secretion and sensitivity after partial hepatectomy in the rat.
Topics: Animals; Blood Glucose; Epinephrine; Glucose; Hepatectomy; Hyperglycemia; Insulin; Insulin Resistanc | 1991 |
Intravesical catheterization through the urethra induces stress hyperglycemia in conscious rats.
Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Animals; Female; Hyperglycemia; Injections, Intraventr | 1990 |
Neostigmine-induced hyperglycemia is mediated by central muscarinic receptor in fed rats.
Topics: Adrenergic Fibers; Animals; Atropine; Brain; Hyperglycemia; Injections, Intraventricular; Male; Neos | 1990 |
Involvement of adrenergic mechanism in hyperglycemia due to SCN stimulation.
Topics: Adrenergic alpha-Antagonists; Animals; Autonomic Nervous System; Electric Stimulation; Female; Gluca | 1989 |
Hyperglycaemia after burn injury.
Topics: Adrenalectomy; Animals; Burns; Glucose Tolerance Test; Hyperglycemia; Insulin; Male; Phentolamine; P | 1989 |
Role of alpha 1- and alpha 2-adrenoceptors in catecholamine-induced hyperglycaemia, lipolysis and insulin secretion in conscious fasted rabbits.
Topics: Animals; Catecholamines; Clonidine; Hyperglycemia; Insulin; Insulin Secretion; Lipolysis; Male; Praz | 1988 |
Influence of cholinergic and adrenergic blocking drugs on hyperglycemia and brain glycogenolysis in diazinon-treated animals.
Topics: Animals; Atropine; Brain; Diazinon; Female; Glucose-6-Phosphatase; Glycogen; Hyperglycemia; Insectic | 1988 |
Hyperglycaemic effect of glucagon administered intracerebroventricularly in the rat.
Topics: Adrenalectomy; Animals; Atropine; Autonomic Nervous System; Blood Glucose; Glucagon; Hexamethonium; | 1985 |
Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Topics: Adult; Blood Glucose; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Growth Hormone; Humans; Hype | 1985 |
Increase in plasma glucose concentration after intracerebroventricular injection of N,O'-dibutyryl cyclic adenosine 3',5'-monophosphate.
Topics: Adenosine Triphosphate; Animals; Atropine; Blood Glucose; Bucladesine; Cyclic AMP; Dibutyryl Cyclic | 1986 |
Hyperglycemia induced by electrical stimulation of lateral part of dorsal parabrachial nucleus.
Topics: Animals; Atropine; Blood Glucose; Electric Stimulation; Female; Glucagon; Hexamethonium; Hexamethoni | 1988 |
Time-dependent involvement of autonomic nervous system in hyperglycemia due to 2-deoxy-D-glucose.
Topics: Animals; Atropine; Autonomic Nervous System; Blood Glucose; Circadian Rhythm; Deoxyglucose; Glucagon | 1988 |
Splanchnic neural regulation of pancreatic polypeptide release in the isolated perfused human pancreas.
Topics: Adolescent; Adult; Aged; Cholinergic Fibers; Electric Stimulation; Female; Humans; Hyperglycemia; Ma | 1989 |
Hypoinsulinemic and hyperglycemic effects of beta-endorphin in rabbits.
Topics: Animals; Atropine; beta-Endorphin; Blood Glucose; Endorphins; Female; Glucagon; Hyperglycemia; Injec | 1986 |
Theophylline toxicity and the beta-adrenergic system.
Topics: Acidosis; Adolescent; Aminophylline; Animals; Catecholamines; Disease Models, Animal; Dogs; Female; | 1985 |
Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
Topics: Adult; Catecholamines; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids, Nonesterified; Glucagon; | 1985 |
Pancreastatin inhibits insulin secretion and stimulates glucagon secretion in mice.
Topics: Animals; Blood Glucose; Carbachol; Chromogranin A; Female; Glucagon; Glucose; Hyperglycemia; Insulin | 1988 |
Desensitization of the insulin receptor by antireceptor antibodies in vivo is blocked by treatment of mice with beta-adrenergic agonists.
Topics: Adipose Tissue; Aminophylline; Animals; Fasting; Hyperglycemia; Immunoglobulin Idiotypes; Insulin; I | 1988 |
Mechanism of the central hyperglycemic action of histamine in mice.
Topics: Adrenalectomy; Animals; Blood Glucose; Chlorpheniramine; Chromatography, High Pressure Liquid; Corti | 1987 |
Increase in the sensitivity of the rat to histamine following injection with Nippostrongylus brasiliensis.
Topics: Allergens; Animals; Blood Glucose; Cortisone; Drug Hypersensitivity; Epinephrine; Histamine; Histami | 1971 |
[Effect of fasting and hypophysectomy on the lipolytic and hyperglycemic action of adrenaline in dogs treated with beta blockaders].
Topics: Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Animals; Blood Glucose; Dogs; Drug Interac | 1974 |
Receptor mechanisms in the hyperglycaemic response to adrenaline in man.
Topics: Drug Synergism; Epinephrine; Gluconeogenesis; Humans; Hyperglycemia; Lactates; Phentolamine; Propran | 1967 |
Metabolic effects of autonomic blockade.
Topics: Blood Glucose; Fatty Acids; Humans; Hyperglycemia; Hypoglycemia; Metabolism; Nicotinic Acids; Phenox | 1967 |
Propranolol and hypoglycaemia.
Topics: Adult; Diabetes Mellitus; Female; Humans; Hyperglycemia; Hypoglycemia; Insulin; Male; Middle Aged; P | 1968 |
[A study of the calorigenic action of catecholamines].
Topics: Adipose Tissue; Animals; Desipramine; Epinephrine; Fatty Acids, Nonesterified; Hyperglycemia; Hypoli | 1968 |
Bordetella pertussis-induced alteration of the normal hyperglycemic response of mice to 3',5'-adenosine phosphate.
Topics: Adenine Nucleotides; Animals; Blood Glucose; Bordetella pertussis; Cyclic AMP; Dibenzylchlorethamine | 1968 |
Inhibitory effect of propranolol on hyperglycemia induced by dibutyryl 3',5'-cyclic AMP.
Topics: Animals; Blood Glucose; Butyrates; Cyclic AMP; Drug Antagonism; Hyperglycemia; Liver; Male; Phosphor | 1972 |
[Effect of an adrenergic beta-blocking agent on adrenaline-induced hyperglycemia in hypophysectomized dogs].
Topics: Adrenalectomy; Adrenocorticotropic Hormone; Animals; Blood Glucose; Dogs; Epinephrine; Hyperglycemia | 1971 |
On the mechanism of the hyperglycaemic effect of chlorpromazine.
Topics: Animals; Blood Glucose; Chlorpromazine; Drug Synergism; Epinephrine; Ethanolamines; Hyperglycemia; N | 1966 |
Glycemic effects of solanine in rats.
Topics: Adrenalectomy; Animals; Blood Glucose; Chlorpromazine; Ergotamine; Female; Glucose Tolerance Test; G | 1967 |
Failure of beta-adrenergic blocking agents to antagonize the hyperglycemic effect of epinephrine in mice.
Topics: Adrenal Glands; Adrenalectomy; Adrenergic beta-Antagonists; Animals; Chlorpromazine; Epinephrine; Hy | 1971 |
[Role of catecholamines in hypoxia and hyperglycemia induced by injection of cystamine].
Topics: Adrenal Medulla; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; | 1971 |
[Six years' experience with a musculoplastic technic].
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists | 1971 |
Blood glucose, growth hormone, and cortisol levels after hypothalamic stimulation.
Topics: Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Animals; Blood Glucose; Cats; Corticostero | 1972 |
Blood sugar responses to epinephrine in the dog in the presence of dual adrenergic blockade.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Glucose; Dogs; Drug Combin | 1972 |
[Study of adrenoline-induced hyperglycemia in bred rainbow trout (Salmo gairdnerii Richardson): action of adrenolytic agents].
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Epinephrine; Hyperglycemia; Phentolamine; Pindo | 1971 |
Effects of propanolol and sotalol on epinephrine-induced hyperglycemia and glycogen depletion of liver and muscle in the rat.
Topics: Animals; Blood Glucose; Epinephrine; Fasting; Female; Glycogen; Hyperglycemia; Injections, Intraperi | 1974 |
Effect of adrenergic blocking agents on sympathomimetic amine induced hyperglycemia and hyperlactacidemia.
Topics: Animals; Blood Glucose; Catecholamines; Columbidae; Dogs; Epinephrine; Female; Hyperglycemia; Isopro | 1974 |
Effect of hyperglycemia and adrenergic stimulation on growth hormone response during hypovolemic shock.
Topics: Animals; Blood Glucose; Growth Hormone; Hyperglycemia; Male; Papio; Phentolamine; Propranolol; Shock | 1974 |
Drug control of hyperglycemia and inhibition of insulin secretion due to centrally administered 2-deoxy-D-glucose.
Topics: Amphetamine; Animals; Atropine; Autonomic Agents; Drug Synergism; Female; Glucose; Hydroxydopamines; | 1973 |
Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects.
Topics: Adult; Blood Glucose; Diabetes Mellitus; Epinephrine; Female; Glucose; Glucose Tolerance Test; Human | 1973 |
Effect of acute uremia on various aspects of carbohydrate metabolism in dogs.
Topics: Acute Disease; Animals; Blood Glucose; Carbohydrate Metabolism; Creatinine; Dogs; Epinephrine; Fasti | 1973 |
[The anti-inflammatory action of adrenaline].
Topics: Adrenal Glands; Adrenalectomy; Animals; Anti-Inflammatory Agents; Blood Glucose; Capillary Permeabil | 1973 |
Narcotic poisoning: an epidemic disease.
Topics: Diazepam; Glucose; Hospitalization; Humans; Hyperglycemia; Methadone; Myelitis, Transverse; Myoglobi | 1973 |
Letter: Propranolol.
Topics: Aged; Female; Humans; Hyperglycemia; Hypoglycemia; Propranolol | 1974 |
Glucagon mediation of growth hormone secretion in juvenile diabetes mellitus.
Topics: Adolescent; Blood Glucose; Body Weight; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Growth H | 1974 |
Hepatic glycogen and blood glucose control.
Topics: Animals; Blood Glucose; Diet; Drug Synergism; Epinephrine; Ergotamine; Fasting; Glucagon; Hyperglyce | 1969 |
Physiological and drug-induced changes in the glycogen content of mouse brain.
Topics: Amphetamine; Animals; Bemegride; Body Temperature; Brain Chemistry; Caffeine; Catecholamines; Circad | 1970 |
Increase in plasma growth hormone concentration in man after infusion of adrenaline-propranolol.
Topics: Adolescent; Adult; Blood Glucose; Epinephrine; Female; Growth Hormone; Humans; Hyperglycemia; Male; | 1970 |
Beta adrenergic receptor mechanisms in the metabolic effects of diazoxide in fasted rats.
Topics: Animals; Blood Glucose; Diazoxide; Fasting; Glycerides; Hyperglycemia; Lactates; Plasma; Propranolol | 1970 |
Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.
Topics: Adult; Antigens; Blood Glucose; Carbon Isotopes; Diabetes Complications; Diabetes Mellitus; Drug Ant | 1970 |
Impairment of hyperglycemic induced growth hormone suppression in hyperthyroidism.
Topics: Blood Glucose; Catecholamines; Growth Hormone; Humans; Hyperglycemia; Hyperthyroidism; Hypothalamo-H | 1968 |